SCHEMBL3862877

SCHEMBL3862877

CCCCOC(=O)CNc1ccc(N)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PDE4D Q08499 1/20 0.47
HCAR3 P49019 3/20 0.43
ALDH1A1 P00352 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HPGD P15428 2/20 0.43
PPARG P37231 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28588234 0.81 RAB9A (0.50) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL30180494 0.81 RAB9A (0.50) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL6434747 0.77 CCNT1 (0.41) HCAR3ALDH1A1KDM4EPPIBPPIA
SCHEMBL13685154 0.75 PTGS1 (0.43) HCAR3
SCHEMBL28120960 0.74 ALOX12 (0.51) LMNACYP3A4TSHRALDH1A1HPGD
SCHEMBL28042930 0.73 TSHR (0.60) LMNACYP1A2CYP3A4TSHRCYP2C9
SCHEMBL6946116 0.72 RAB9A (0.58) LMNATSHRALDH1A1NPC1RAB9A
SCHEMBL11707466 0.71 HCAR3 (0.57) LMNAHCAR3ALDH1A1RAB9AHPGD
SCHEMBL2556214 0.70 ALDH1A1 (0.44) LMNACYP1A2TSHRALDH1A1HPGD
SCHEMBL2911978 0.70 HCAR3 (0.56) LMNAHCAR3ALDH1A1HPGDHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1047425-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-22 EP disclosed
EP-1047425-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-11-02 EP disclosed
WO-1999030709-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed